Article Details
Retrieved on: 2024-10-22 20:39:22
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses updated FDA guidance emphasizing the use of data analytics and AI for compliance in FDA-regulated industries, highlighting the importance of data governance, regulatory compliance, and training overseen by chief compliance officers within corporate governance frameworks.
Article found on: www.jdsupra.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here